Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Eve Investments.
RELATED STOCKHEAD STORIES
News
Rise & Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
News
Weed Week: US looks at ways to help cannabis players get banking access
Health & Biotech
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
News
Weekly ASX small cap wrap: Who’s been batting 100 this week?
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Health & Biotech
The Pot Seat: Eve’s Ben Rohr says cannabis honey could be a thing in 2021
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
Food & Agriculture
Cannabis: THC is allowed to export, but still no sign of one crucial licence
Health & Biotech
These six Aussie pot stocks raised 70pc of cannabis capital in 2018
Health & Biotech
Cannabis investor EVE gains 12pc after finalising lease of pot site to Hydroponics Co
Health & Biotech
Eve buys a tea tree farm, solidifies position as cannabis purveyor
Health & Biotech
THC’s got a new pot plot – but it’s still waiting on a growing licence
Health & Biotech
Here’s how much money ASX cannabis stocks made last quarter
Health & Biotech
Which ASX pot stocks hold those golden Aussie cannabis licences
Food & Agriculture
EVE hopes it won’t get stung on Chinese honey water play
News
